HappeningToo topic
Fluticasone Propionate and Salmeterol Xinafoate reports
Browse community reports connected to Fluticasone Propionate and Salmeterol Xinafoate. These reports can show that other people are describing similar experiences, but they do not prove that Fluticasone Propionate and Salmeterol Xinafoate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
36 problems
Abdominal Discomfort while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and abdominal discomfort appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and abdominal pain upper appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and abdominal pain appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and acid reflux appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and anxiety appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and back pain appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and chest discomfort appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and constipation appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and cough appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and decreased appetite appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and diarrhea appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and dizziness appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and excessive sweating appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and fatigue appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and feeling abnormal appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and headache appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and heart rate increased appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and hives appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and insomnia appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and itching appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and malaise appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and muscle spasms appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and myalgia appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and nausea appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and oropharyngeal pain appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and pain appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Erythematous while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and rash erythematous appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and rash appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and shortness of breath appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and skin redness appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and swelling appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and tremor appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and vomiting appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and weakness appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and weight decreased appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Fluticasone Propionate and Salmeterol Xinafoate
FDA FAERS contains adverse-event reports in which Fluticasone Propionate and Salmeterol Xinafoate and weight increased appear together. This does not establish that Fluticasone Propionate and Salmeterol Xinafoate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →